FDA grants Orchestra BioMed a breakthrough device designation for its Virtue Sirolimus-eluting Balloon for treating coronary in-stent restenosis.
FDA warns Empire Distributors it is illegally marketing an unapproved new drug that also is misbranded.
Public Citizen and others ask the Supreme Court not to grant a broader exemption to the Freedom of Information Act sought by the Food Marketing Instit...
AdvaMed asks FDA to make changes to improve its draft guidance on non-binding feedback after medical device establishment inspections.
CDER issues a MAPP with policies and procedures for its new Biopharmaceutics Council.
FDA approves B. Braun Medicals 5,000-unit prefilled heparin sodium injection, USP.
Federal Register notice: FDA has announced a 5/16 public meeting entitled Characterizing FDAs Approach to Benefit-Risk Assessment Throughout the Medic...
Federal Register notice: FDA announces a 6/6 Antimicrobial Drugs Advisory Committee meeting to discuss a Global Alliance for TB Drug Development NDA f...